3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms, Castration-Resistant
1
Metastatic Castration Resistant Prostate Cancer
1
Interventions
enzalutamide
4
abiraterone
2
Docetaxel
2
tasquinimod
1
sabizabulin
1
olaparib
1
ipatasertib
1
darolutamide
1
atezolizumab
1
Nivolumab
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Prostatic Neoplasms, Castration-Resistant
×
sabizabulin
×
Clear all
NCT04844749
2024-02-05
VERACITY
Veru Inc.
Phase 3
Terminated
105 enrolled